Investing
Fund Manager: Gold Stocks a Strategic Opportunity for Investors
Over the last several years, gold has reasserted itself as a safe-haven investment against a backdrop of inflation, geopolitical turmoil and...
Read more
FPX Nickel Provides Update on Affiliate Company CO2 Lock Corp.
FPX Nickel Corp. (TSX-V: FPX) (OTCQB: FPOCF) (‘ FPX ‘ or the ‘ Company ‘) is pleased to provide an update...
Read more
Lode Gold Leverages Artificial Intelligence to Drive Exploration and Growth in Yukon
Lode Gold Resources Inc. (TSXV: LOD) (OTCQB: LODFF) (‘Lode Gold’ or the ‘Company’) is pleased to announce it will be...
Read more
TSX Hits Record High Amid Gold Price Surge and Easing Trade Tensions
The S&P/TSX Composite Index (INDEXTSI:JX)reached a new all-time high of 26,105.67 as markets opened on Tuesday (May 20), representing a...
Read more
Metals Focus: PGMs Deficits Deepen as Supply Tightens and Demand Realigns
Despite economic and geopolitical upheaval, 2024 was relatively calm for platinum-group metals (PGMs). In its new PGMs report, research firm...
Read more
Regulator: New York Taking Strong Steps in Bid to Become World’s “Crypto Capital”
In the absence of unified federal legislation on cryptocurrencies, New York is establishing its own comprehensive regulations for the sector...
Read more
NorthStar Gaming Announces Revocation of Management Cease Trade Order
NorthStar Gaming Holdings Inc. (TSXV: BET) (OTCQB: NSBBF) (‘NorthStar’ or the ‘Company’) is pleased to announce that effective May 16,...
Read more
Canaccord Global Mining Conference Presentation
Brightstar Resources (BTR:AU) has announced Canaccord Global Mining Conference Presentation Download the PDF here. This post appeared first on investingnews.com
Read more
5 Small-cap Biotech ETFs to Watch
Thanks to exchange-traded funds (ETFs), investors don’t have to be tied to one specific stock. When it comes to biotech...
Read more
ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177
ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, and Radiopharm Theranostics (ASX:RAD; NASDAQ: RADX ‘Radiopharm’), a developer...
Read more
